Regulatory12 Aug 2026, 07:30 pm
Kabra Drugs Ltd: Undertaking for Non-Applicability of Reg 32
AI Summary
Kabra Drugs Ltd (now Aanjaay Industries Limited) has submitted an undertaking to the stock exchange stating that Regulation 32 of SEBI (LODR) Regulations, 2015 is not applicable to the company for the quarter ended June 30, 2026. This is because the company has not undertaken any public issue, rights issue, or preferential issue during the specified period. Regulation 32 mandates the submission of statements detailing deviations in the use of proceeds from offer documents.
Key Highlights
- Company confirms non-applicability of SEBI Regulation 32.
- No public, rights, or preferential issues were made by the company.
- Undertaking submitted for the quarter ending June 30, 2026.
- Kabra Drugs is now known as Aanjaay Industries Limited.
Price Impact
More from KABRADG